Skip to content
OpenCapital
Get started

Warby Parker WRBY Operating Loss Carryforwards

Operating Loss Carryforwards at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
——
HRO
HarrowHROW
——

Other financials

Income statement

See full
Revenue$242.4M+8.3%
Gross profit$131.0M+4.0%
Operating income$1.7M-32.5%
Net income$3.2M-8.5%
EPS (diluted)$0.030.0%

Balance sheet

See full
Cash & equivalents$288.2M+8.7%
Total debt$237.6M+6.2%
Total equity$375.8M+6.1%
Total assets$736.4M+7.9%

Cash flow

See full
Operating cash flow$24.5M-16.5%
CapEx$16.1M-0.1%
Free cash flow$8.4M-36.6%

Valuation

See full
Market cap$3.15B+17.1%

Profitability

See full
Gross margin53.4%-1.8pp
Operating margin-0.7%-0.3pp
Net margin0.1%0.0pp
FCF margin4.5%-0.8pp

Returns & leverage

See full
Return on equity0.2%+0.1pp
Debt / equity0.6×0.0×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by Warby Parker in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The official record: Warby Parker’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Warby Parker's operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Warby Parker's operating loss carryforwards?
Warby Parker (WRBY) reported operating loss carryforwards of $299.9M in Q4 2025.
How has Warby Parker's operating loss carryforwards changed year-over-year?
Warby Parker's operating loss carryforwards decreased by 1.8% year-over-year, from $305.5M to $299.9M.
What is the long-term trend for Warby Parker's operating loss carryforwards?
Over 4 years (2021 to 2025), Warby Parker's operating loss carryforwards has grown at a -3.7% compound annual growth rate (CAGR), from $348.9M to $299.9M.